Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O0JO
|
||||
Former ID |
DNC011256
|
||||
Drug Name |
N-(2-chlorobenzyl)-5-(4-chlorophenyl)nicotinamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [531169] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H14Cl2N2O
|
||||
Canonical SMILES |
C1=CC=C(C(=C1)CNC(=O)C2=CN=CC(=C2)C3=CC=C(C=C3)Cl)Cl
|
||||
InChI |
1S/C19H14Cl2N2O/c20-17-7-5-13(6-8-17)15-9-16(11-22-10-15)19(24)23-12-14-3-1-2-4-18(14)21/h1-11H,12H2,(H,23,24)
|
||||
InChIKey |
CKNIOMWTEPBNFF-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | PN3 Na+ channel | Target Info | Inhibitor | [531169] | |
Voltage-gated sodium channel subunit alpha Nav1.8 | Target Info | Inhibitor | [531169] | ||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.